Viewing Study NCT00004486



Ignite Creation Date: 2024-05-05 @ 9:36 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004486
Status: COMPLETED
Last Update Posted: 2015-03-25
First Post: 1999-10-18

Brief Title: Randomized Study of Fluoxetine in Children and Adolescents With Autism
Sponsor: Icahn School of Medicine at Mount Sinai
Organization: FDA Office of Orphan Products Development

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2000-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: OBJECTIVES I Evaluate the efficacy of fluoxetine on social and language deficits global severity and compulsive dimensions of children and adolescents with autism

II Assess the effectiveness of this treatment regimen on neurocognitive deficits in this patient population

III Compare the baseline compulsive severity and treatment outcome in these patients
Detailed Description: PROTOCOL OUTLINE This is a randomized double blind placebo controlled crossover study All patients receive oral placebo daily during week 0

Patients are randomized to receive either oral fluoxetine or oral placebo daily on weeks 1-8 Patients then crossover to receive treatment on the other arm during weeks 12-20

Completion date provided represents the completion date of the grant per OOPD records

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
MTS-GCO-96-713 None None None
MTS-FDR001520 None None None